Old Web
English
Sign In
Acemap
>
authorDetail
>
T Bourlard
T Bourlard
Pathology
Trastuzumab
Vinorelbine
Regimen
Medicine
3
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Optimal tolerance of an all-oral combination chemotherapy (CT) of oral vinorelbine (NVBo), capecitabine (C) with/without trastuzumab (T) in metastatic breast cancer (MBC) patients (pts): Safety Results of two international multicenter studies
2016
Journal of Clinical Oncology
Arlene Chan
N. Tubiana
Vinod Ganju
Pierfranco Conte
Philippe Bougnoux
D. Aubert
T Bourlard
D. Becquart
Show All
Source
Cite
Save
Citations (3)
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial
2006
British Journal of Cancer
A Chan
Miguel Martín
Michael Untch
M Gil
V. Guillem-Porta
M Z Wojtukiewicz
P. Kellokumpu-Lehtinen
H L Sommer
V Georgoulias
N. Battelli
M. Pawlicki
D. Aubert
T Bourlard
J. Gasmi
G Villanova
Lubos Petruzelka
Show All
Source
Cite
Save
Citations (48)
Rhamnogalacturonans I and II are pectic substrates for flax-cell methyltransferases
1997
Plant Physiology and Biochemistry
T Bourlard
P. Pellerin
C. Morvan
Show All
Source
Cite
Save
Citations (8)
1